Gregory Norden
Independent Director
Former Chief Financial Officer, Wyeth
Director since
January 2013
Committees
Audit (Chair); Corporate Governance
Other Current Public Company Directorships
Praxis Precision Medicines, Inc. (since March 2019)
Royalty Pharma plc (since June 2020)
Mr. Norden has over 20 years of leadership and financial management experience in global healthcare and pharmaceuticals. He provides exceptional financial and accounting expertise from his role as the former Chief Financial Officer of Wyeth, with comprehensive knowledge of reporting requirements, disclosure rules and audit committee responsibilities. He brings 13 years of institutional knowledge as chair of the Audit Committee, with extensive expertise in working with internal and external audit teams and navigating complex financial and compliance matters.
Skills and Qualifications
Animal Health
Consumer Products
Global Businesses
Human Capital Management
Life Sciences
Mergers and Acquisitions
Other Public Company Board Member
Public Company CFO; or Finance and Accounting
Throughout his tenure at Wyeth, where he had broad responsibilities for many of the company’s global functional areas and businesses, and later in his role as corporate CFO at Wyeth, he worked with a broad range of human and animal health businesses, including Fort Dodge Animal Health, a manufacturer of animal health products, that was part of Wyeth, bringing a deep understanding of the industry to the Board.
Audit and accounting expertise acquired from experience as Audit Manager at Arthur Andersen & Co., working primarily with multinational companies in the life sciences, consumer products and financial services industries, with a comprehensive knowledge of reporting rules, disclosure requirements and the critical role of external auditors.
Deep expertise in creating and executing high impact strategic and operational global corporate initiatives, including as one of the lead architects/negotiators of the $68 billion Pfizer acquisition of Wyeth, which enhances Board discussions on major acquisitions and alliances and the Company’s capital allocation strategy.
Extensive board experience, currently serving on the board of directors of Praxis Precision Medicines and Royalty Pharma, as well as previous service on the boards of directors of Human Genome Sciences, Welch Allyn, Univision, Entasis, nanoString Technologies and Anthos.
Career Highlights
Wyeth (acquired by Pfizer in 2009) – a global pharmaceutical and healthcare products company
- Chief Financial Officer (2007-2009)
- Executive Vice President and Chief Financial Officer of Wyeth Pharmaceuticals, Inc. (2000-2007)
- Various senior positions (1989-2000)
Arthur Andersen & Co. – a global accounting firm
- Audit Manager (1983-1989)
G9 Capital Group LLC – provider of corporate advisory services to companies, family offices and leading venture capital and private equity firms
- Managing Director (2010-2025)
Education
- Bachelor’s degree in Management and Economics from State University of New York at Plattsburgh
- Master of Science in Accounting from LIU Post